Reply

Am J Ophthalmol. 2017 May:177:229. doi: 10.1016/j.ajo.2017.02.008. Epub 2017 Mar 18.

Authors

Rupin N Parikh¹, Anastasia Traband², Anton M Kolomeyer², Brian L VanderBeek², Benjamin J Kim², Albert M Maguire², Alexander J Brucker²

Affiliations

¹ Philadelphia, Pennsylvania, and Albany, New York.
² Philadelphia, Pennsylvania.

PMID: 28325547
DOI: 10.1016/j.ajo.2017.02.008

No abstract available

Publication types

Letter
Comment

MeSH terms

Bevacizumab
Diabetic Retinopathy*
Humans
Vitreous Hemorrhage*

Substances

Bevacizumab